Table 3 Selected intra-operative considerations of patients subjected to single dose regimen during elective orthopedic surgery
Variable | Ceftriaxone (Group A) | Cefepime (Group B) | p-value |
|---|---|---|---|
N = 113 | N = 117 | ||
Hemoglobin Level | |||
Mean | 11.6 g/dl | 11.3 g/dl | 0.577 |
Range | 6–17.2 g/dl | 5.8–16 g/dl | |
SDEV | 2.17 g/dl | 2.10 g/dl | |
Timing of prophylaxis [within] | |||
<15 min | 65 (56 %) | 57 (48.7 %) | 0.408 |
>16– < 30 min | 43 (38.0 %) | 54 (46.2 %) | |
>31– < 45 min | 5 (6.0 %) | 6 (5.1 %) | |
>46 < 60 min | 0 | 0 | |
Approximate blood loss | |||
Less than 400 ml | 93 (82.3 %) | 88 (75.2 %) | 0.189 |
More than 400 ml | 20 (17.7 %) | 29 (24.20 %) | |
Duration of operation [within] | |||
<1 h | 60 (53.1 %) | 58 (49.6 %) | 0.864 |
2 h | 43 (38.1 %) | 45 (38.5 %) | |
3 h | 9 (8.0 %) | 13 (11.1 %) | |
4 or More hours | 1 (0.8 %) | 1 (0.8 %) | |
ASA Classification | |||
ASA 1 | 105 (92.92 %) | 102 (87.18 %) | 0.116 |
ASA 2 | 7 (6.19 %) | 15 (12.82 %) | |
ASA 3 | 1 (0.88) | 0.00 | |